Baoqi Yu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Baoqi Yu has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
- Aijuan Qu
Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Capital Medical University; Key Laboratory of Remodeling-Related Cardiovascular Diseases, Ministry of Education, Beijing, China
4 shared publications Qiuyue Gao
Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Laboratory for Clinical Medicine, Capital Medical University, Beijing, China
4 shared publicationsCaihua Long
Department of Basic Medical Sciences, Capital Medical University, Beijing, China
2 shared publications- Chen Zhang
School of Basic Medical Sciences, Beijing Key Laboratory of Neural Regeneration and Repair, Capital Medical University, Beijing, China
2 shared publications - Qingbo Xu
Department of Cardiology, The First Affiliated Hospital, Zhejiang University School of Medicine
2 shared publications - Xian Xu
Department of Radiology, The Second Medical Centre, National Clinical Research Center of Geriatric Diseases, Chinese PLA General Hospital, Beijing, China
2 shared publications
Latest Publications
- 26 October 2026
- Published by Springer Nature in Heart and Vessels
- p. 1-16
Sca1⁺ stem cells contribute to β-Aminopropionitrile-exacerbated aortic aneurysm progression in marfan syndrome
- 26 October 2026
- Published by Springer Nature in Heart and Vessels
- p. 1-16
Sca1⁺ stem cells contribute to β-Aminopropionitrile-exacerbated aortic aneurysm progression in marfan syndrome
- Open Access
- 21 July 2026
- Published by AccScience Publishing in Global Translational Medicine
- Vol. 5 (3) , 025350068
Vascular organoids in cardiovascular medicine: From stem cell biology to precision medicine
Cardiovascular diseases remain the leading cause of death worldwide. However, conventional therapies incompletely address disease heterogeneity, and conventional in vitro models do not accurately recapitulate the complex vascular microenvironment. Embryonic stem cells, induced pluripotent stem cells, and adult stem cells, including adipose-derived mesenchymal stem cells and bone marrow mesenchymal stem cells, provide a robust cellular foundation for constructing functional vascular networks through multidirectional differentiation and paracrine signaling. Advanced technologies for generating vascularized organoids, including co-culture systems, bioprinting, and growth factor modulation, have markedly enhanced organoid survival, structural stability, and physiological fidelity. These organoids have enabled the formation of functional vascular networks in multiple organ systems, including the brain, kidney, and heart, while faithfully reproducing both disease-associated pathological features and normal physiological functions. As a result, they serve as versatile platforms for investigating mechanisms of vascular disease, performing high-throughput drug screening, evaluating drug efficacy and toxicity, and developing personalized therapeutic strategies. Furthermore, vascularized organoids facilitate mechanistic studies on angiogenesis, vascular remodeling, and cell–cell interactions within physiologically relevant three-dimensional contexts, offering insights that are difficult to obtain from conventional two-dimensional cultures or animal models. This review systematically summarizes the roles of various stem cells in angiogenesis, outlines strategies for constructing vascularized organoids, and highlights their emerging applications in modeling vascular-associated diseases and regenerative therapy, providing a comprehensive reference for advancing both basic research and clinical translation in vascular medicine.
- 21 July 2026
- Published by AccScience Publishing in Global Translational Medicine
- Vol. 5 (3) , 025350068
Open AccessVascular organoids in cardiovascular medicine: From stem cell biology to precision medicine
Cardiovascular diseases remain the leading cause of death worldwide. However, conventional therapies incompletely address disease heterogeneity, and conventional in vitro models do not accurately recapitulate the complex vascular microenvironment. Embryonic stem cells, induced pluripotent stem cells, and adult stem cells, including adipose-derived mesenchymal stem cells and bone marrow mesenchymal stem cells, provide a robust cellular foundation for constructing functional vascular networks through multidirectional differentiation and paracrine signaling. Advanced technologies for generating vascularized organoids, including co-culture systems, bioprinting, and growth factor modulation, have markedly enhanced organoid survival, structural stability, and physiological fidelity. These organoids have enabled the formation of functional vascular networks in multiple organ systems, including the brain, kidney, and heart, while faithfully reproducing both disease-associated pathological features and normal physiological functions. As a result, they serve as versatile platforms for investigating mechanisms of vascular disease, performing high-throughput drug screening, evaluating drug efficacy and toxicity, and developing personalized therapeutic strategies. Furthermore, vascularized organoids facilitate mechanistic studies on angiogenesis, vascular remodeling, and cell–cell interactions within physiologically relevant three-dimensional contexts, offering insights that are difficult to obtain from conventional two-dimensional cultures or animal models. This review systematically summarizes the roles of various stem cells in angiogenesis, outlines strategies for constructing vascularized organoids, and highlights their emerging applications in modeling vascular-associated diseases and regenerative therapy, providing a comprehensive reference for advancing both basic research and clinical translation in vascular medicine.
- Open Access
- 17 December 2025
- Published by OAE Publishing Inc. in Vessel Plus
- Vol. 9
Stem cell-based strategies for vascular aging: from mechanistic insights to clinical translation
Vascular aging serves as a key driver of cardiovascular diseases, contributing significantly to the increasing global burden of morbidity and mortality. During vascular aging, stem cell senescence perturbs vascular homeostasis through impaired regeneration, increased oxidative stress, and chronic inflammation. Ultimately, it accelerates the development of vascular pathologies, such as atherosclerosis and aneurysm formation. This review aims to elucidate the roles of senescent vascular stem cells in the progression of vascular aging and also to explore the therapeutic potential of stem cell-based interventions in the management of cardiovascular diseases. It comprehensively includes various stem cell types, as well as their derived substances, elaborating on their roles in vascular aging and repair. Centered on "vascular stem cell senescence", it systematically elucidates the causal relationships among stem cell senescence, vascular homeostasis disruption, and the development of cardiovascular diseases, thereby constructing a focused and coherent mechanistic framework for understanding the pathological process of vascular aging. By integrating cross-system factors, including gut microbiota dysbiosis, renin-angiotensin system dysregulation, and abnormal hemodynamics, this review reveals the multi-system interactions underlying vascular aging. Moreover, it emphasizes translational rigor by not only introducing preclinical advancements but also objectively analyzing technical bottlenecks and clinical limitations, and further pointing out directions for future research. Overall, this review clarifies the roles of senescent vascular stem cells in vascular aging and the therapeutic potential of stem cell-based interventions for cardiovascular diseases, providing valuable references for promoting the clinical translation of stem cell-based strategies in the management of vascular aging-related cardiovascular diseases.
- 17 December 2025
- Published by OAE Publishing Inc. in Vessel Plus
- Vol. 9
Open AccessStem cell-based strategies for vascular aging: from mechanistic insights to clinical translation
Vascular aging serves as a key driver of cardiovascular diseases, contributing significantly to the increasing global burden of morbidity and mortality. During vascular aging, stem cell senescence perturbs vascular homeostasis through impaired regeneration, increased oxidative stress, and chronic inflammation. Ultimately, it accelerates the development of vascular pathologies, such as atherosclerosis and aneurysm formation. This review aims to elucidate the roles of senescent vascular stem cells in the progression of vascular aging and also to explore the therapeutic potential of stem cell-based interventions in the management of cardiovascular diseases. It comprehensively includes various stem cell types, as well as their derived substances, elaborating on their roles in vascular aging and repair. Centered on "vascular stem cell senescence", it systematically elucidates the causal relationships among stem cell senescence, vascular homeostasis disruption, and the development of cardiovascular diseases, thereby constructing a focused and coherent mechanistic framework for understanding the pathological process of vascular aging. By integrating cross-system factors, including gut microbiota dysbiosis, renin-angiotensin system dysregulation, and abnormal hemodynamics, this review reveals the multi-system interactions underlying vascular aging. Moreover, it emphasizes translational rigor by not only introducing preclinical advancements but also objectively analyzing technical bottlenecks and clinical limitations, and further pointing out directions for future research. Overall, this review clarifies the roles of senescent vascular stem cells in vascular aging and the therapeutic potential of stem cell-based interventions for cardiovascular diseases, providing valuable references for promoting the clinical translation of stem cell-based strategies in the management of vascular aging-related cardiovascular diseases.
- 20 June 2025
- Published by MyJove Corporation in Journal of Visualized Experiments
- No. 220,p. e68433
Precision Ultrasound-guided Stem Cell Delivery for Vascular Repair in Aortic Diseases
Aortic aneurysms and dissections rupture are life-threatening cardiovascular emergencies. Early prevention and control of disease progression are essential for improving patient outcomes. Vascular stem cells play a crucial role in the repair of vascular injuries across various vascular diseases. However, intravascular stem cell injection therapies encounter challenges in ensuring efficient engraftment of exogenous stem cells within the vascular wall. To explore a more effective and minimally invasive approach for delivering stem cells in aortic diseases, we developed an ultrasound-guided precision-targeted stem cell delivery technology. Specifically, the technique utilized an ultra-high-resolution small animal color Doppler ultrasound imaging system to precisely locate the vascular wall of the ascending aorta in aortic disease mouse models. Subsequently, 1 × 106 mCherry-labeled vascular stem cells mixed within 25 µL of Matrigel were injected using a 29 G needle. The progression of the disease was monitored by small animal ultrasound. Finally, the aorta was harvested and analyzed using 3D imaging with a light sheet microscope to track injected vascular stem cells. The above results demonstrate that the injected vascular stem cells were delivered accurately to the vascular wall of the ascending aorta with minimal invasiveness, thereby effectively promoting vascular repair in aortic aneurysms and dissections. This ultrasound-guided stem cell delivery technology offers a promising, minimally invasive method for stem cell transplantation, potentially controlling the progression of aortic aneurysms and dissections and other related cardiovascular diseases in clinics in the future.
- 20 June 2025
- Published by MyJove Corporation in Journal of Visualized Experiments
- No. 220,p. e68433
Precision Ultrasound-guided Stem Cell Delivery for Vascular Repair in Aortic Diseases
Aortic aneurysms and dissections rupture are life-threatening cardiovascular emergencies. Early prevention and control of disease progression are essential for improving patient outcomes. Vascular stem cells play a crucial role in the repair of vascular injuries across various vascular diseases. However, intravascular stem cell injection therapies encounter challenges in ensuring efficient engraftment of exogenous stem cells within the vascular wall. To explore a more effective and minimally invasive approach for delivering stem cells in aortic diseases, we developed an ultrasound-guided precision-targeted stem cell delivery technology. Specifically, the technique utilized an ultra-high-resolution small animal color Doppler ultrasound imaging system to precisely locate the vascular wall of the ascending aorta in aortic disease mouse models. Subsequently, 1 × 106 mCherry-labeled vascular stem cells mixed within 25 µL of Matrigel were injected using a 29 G needle. The progression of the disease was monitored by small animal ultrasound. Finally, the aorta was harvested and analyzed using 3D imaging with a light sheet microscope to track injected vascular stem cells. The above results demonstrate that the injected vascular stem cells were delivered accurately to the vascular wall of the ascending aorta with minimal invasiveness, thereby effectively promoting vascular repair in aortic aneurysms and dissections. This ultrasound-guided stem cell delivery technology offers a promising, minimally invasive method for stem cell transplantation, potentially controlling the progression of aortic aneurysms and dissections and other related cardiovascular diseases in clinics in the future.
- 20 June 2025
- Published by MyJove Corporation
- No. 220,p. e68433
JoVE Video Dataset
Aortic aneurysms and dissections rupture are life-threatening cardiovascular emergencies. Early prevention and control of disease progression are essential for improving patient outcomes. Vascular stem cells play a crucial role in the repair of vascular injuries across various vascular diseases. However, intravascular stem cell injection therapies encounter challenges in ensuring efficient engraftment of exogenous stem cells within the vascular wall. To explore a more effective and minimally invasive approach for delivering stem cells in aortic diseases, we developed an ultrasound-guided precision-targeted stem cell delivery technology. Specifically, the technique utilized an ultra-high-resolution small animal color Doppler ultrasound imaging system to precisely locate the vascular wall of the ascending aorta in aortic disease mouse models. Subsequently, 1 × 106 mCherry-labeled vascular stem cells mixed within 25 µL of Matrigel were injected using a 29 G needle. The progression of the disease was monitored by small animal ultrasound. Finally, the aorta was harvested and analyzed using 3D imaging with a light sheet microscope to track injected vascular stem cells. The above results demonstrate that the injected vascular stem cells were delivered accurately to the vascular wall of the ascending aorta with minimal invasiveness, thereby effectively promoting vascular repair in aortic aneurysms and dissections. This ultrasound-guided stem cell delivery technology offers a promising, minimally invasive method for stem cell transplantation, potentially controlling the progression of aortic aneurysms and dissections and other related cardiovascular diseases in clinics in the future.
- 20 June 2025
- Published by MyJove Corporation
- No. 220,p. e68433
JoVE Video Dataset
Aortic aneurysms and dissections rupture are life-threatening cardiovascular emergencies. Early prevention and control of disease progression are essential for improving patient outcomes. Vascular stem cells play a crucial role in the repair of vascular injuries across various vascular diseases. However, intravascular stem cell injection therapies encounter challenges in ensuring efficient engraftment of exogenous stem cells within the vascular wall. To explore a more effective and minimally invasive approach for delivering stem cells in aortic diseases, we developed an ultrasound-guided precision-targeted stem cell delivery technology. Specifically, the technique utilized an ultra-high-resolution small animal color Doppler ultrasound imaging system to precisely locate the vascular wall of the ascending aorta in aortic disease mouse models. Subsequently, 1 × 106 mCherry-labeled vascular stem cells mixed within 25 µL of Matrigel were injected using a 29 G needle. The progression of the disease was monitored by small animal ultrasound. Finally, the aorta was harvested and analyzed using 3D imaging with a light sheet microscope to track injected vascular stem cells. The above results demonstrate that the injected vascular stem cells were delivered accurately to the vascular wall of the ascending aorta with minimal invasiveness, thereby effectively promoting vascular repair in aortic aneurysms and dissections. This ultrasound-guided stem cell delivery technology offers a promising, minimally invasive method for stem cell transplantation, potentially controlling the progression of aortic aneurysms and dissections and other related cardiovascular diseases in clinics in the future.
- Open Access
- 21 November 2024
- Published by AccScience Publishing in Global Translational Medicine
- Vol. 3 (4) , 4619
Senescence in cardiovascular diseases: Insights into metabolic dysfunction in vascular cells
Senescence is an independent risk factor and plays a critical role in altering vascular structure and functions. Reportedly, senescence accelerates pathological processes and notably increases the risk of cardiovascular diseases, such as atherosclerosis, which are the leading causes of mortality worldwide. Therefore, understanding vascular senescence mechanisms is essential for controlling the increasing incidence and mortality of cardiovascular diseases. This review highlights the progress in research on the various mechanisms underlying the senescence of endothelial cells, smooth muscle cells, and macrophages – such as stem cell senescence, metabolic dysregulation, mitochondrial autophagy (mitophagy) impairment, and ferroptosis – and summarizes various antisenescence strategies to target these mechanisms. Key interventions include restoration of the nicotinamide adenine dinucleotide/reduced nicotinamide adenine dinucleotide (NAD+/NADH) ratio and administration of metformin and acarbose to regulate blood glucose levels, which balances the cellular energy and redox. Further, stem cell therapies, rapamycin administration, and melatonin supplementation demonstrate substantial potential. In addition, exercise, dietary modification, and caloric restriction support senescence mitigation. These strategies illustrate the multifaceted nature of senescence and highlight the potential of integrated therapeutic approaches to extend the health span and delay age-related diseases. This review provides a comprehensive summary of age-related metabolic pathways and explores promising antisenescence therapeutic strategies, thereby providing valuable insights into the prevention, diagnosis, and treatment of senescence-related vascular diseases.
- 21 November 2024
- Published by AccScience Publishing in Global Translational Medicine
- Vol. 3 (4) , 4619
Open AccessSenescence in cardiovascular diseases: Insights into metabolic dysfunction in vascular cells
Senescence is an independent risk factor and plays a critical role in altering vascular structure and functions. Reportedly, senescence accelerates pathological processes and notably increases the risk of cardiovascular diseases, such as atherosclerosis, which are the leading causes of mortality worldwide. Therefore, understanding vascular senescence mechanisms is essential for controlling the increasing incidence and mortality of cardiovascular diseases. This review highlights the progress in research on the various mechanisms underlying the senescence of endothelial cells, smooth muscle cells, and macrophages – such as stem cell senescence, metabolic dysregulation, mitochondrial autophagy (mitophagy) impairment, and ferroptosis – and summarizes various antisenescence strategies to target these mechanisms. Key interventions include restoration of the nicotinamide adenine dinucleotide/reduced nicotinamide adenine dinucleotide (NAD+/NADH) ratio and administration of metformin and acarbose to regulate blood glucose levels, which balances the cellular energy and redox. Further, stem cell therapies, rapamycin administration, and melatonin supplementation demonstrate substantial potential. In addition, exercise, dietary modification, and caloric restriction support senescence mitigation. These strategies illustrate the multifaceted nature of senescence and highlight the potential of integrated therapeutic approaches to extend the health span and delay age-related diseases. This review provides a comprehensive summary of age-related metabolic pathways and explores promising antisenescence therapeutic strategies, thereby providing valuable insights into the prevention, diagnosis, and treatment of senescence-related vascular diseases.
- 13 December 2023
- Published by Springer Nature in Journal of Cardiovascular Translational Research
- Vol. 17 (1) , 133-152
Diabetes Mellitus to Accelerated Atherosclerosis: Shared Cellular and Molecular Mechanisms in Glucose and Lipid Metabolism
Diabetes is one of the critical independent risk factors for the progression of cardiovascular disease, and the underlying mechanism regarding this association remains poorly understood. Hence, it is urgent to decipher the fundamental pathophysiology and consequently provide new insights into the identification of innovative therapeutic targets for diabetic atherosclerosis. It is now appreciated that different cell types are heavily involved in the progress of diabetic atherosclerosis, including endothelial cells, macrophages, vascular smooth muscle cells, dependence on altered metabolic pathways, intracellular lipids, and high glucose. Additionally, extensive studies have elucidated that diabetes accelerates the odds of atherosclerosis with the explanation that these two chronic disorders share some common mechanisms, such as endothelial dysfunction and inflammation. In this review, we initially summarize the current research and proposed mechanisms and then highlight the role of these three cell types in diabetes-accelerated atherosclerosis and finally establish the mechanism pinpointing the relationship between diabetes and atherosclerosis. Graphical Abstract Initiation and progression of diabetic atherosclerosis. Insulin resistance with hyperinsulinemia, hyperglycemia and lipotoxicity contribute to multiple processes including AGEs production, increased FFA and ox-LDL, which together lead to endothelial dysfunction, macrophages-derived foam cell formation, and VSMCs phenotypic switch. In the early stages of diabetic atherosclerosis, circulating monocytes bind to adhesion factors expressed by activated endothelial cell, while endothelial cells release chemokines that promote migration of the bound monocytes into the arterial wall. After entering the intima, monocytes mature into macrophages, including pro-inflammatory M1 and anti-inflammatory M2 types, macrophages engulf retained ox-LDL and transform into lipidloaded macrophage. At the same time, DCs increased local inflammation of endothelial cells and activated VSMCs. VSMCs in the media proliferate and migrate to the intima, forming a fibrous cap to cover the necrotic core. VSMCs and macrophages can undergo cell death, including apoptosis, pyroptosis, ferroptosis, necroptosis, cell fragments gathered and formed lipid-rich necrotic cores. Fiber caps became thinner, plaque vulnerability increased and rupture, platelet activation led to the formation of thrombosis, and NETosis promoted the formation of thrombosis.
- 13 December 2023
- Published by Springer Nature in Journal of Cardiovascular Translational Research
- Vol. 17 (1) , 133-152
Diabetes Mellitus to Accelerated Atherosclerosis: Shared Cellular and Molecular Mechanisms in Glucose and Lipid Metabolism
Diabetes is one of the critical independent risk factors for the progression of cardiovascular disease, and the underlying mechanism regarding this association remains poorly understood. Hence, it is urgent to decipher the fundamental pathophysiology and consequently provide new insights into the identification of innovative therapeutic targets for diabetic atherosclerosis. It is now appreciated that different cell types are heavily involved in the progress of diabetic atherosclerosis, including endothelial cells, macrophages, vascular smooth muscle cells, dependence on altered metabolic pathways, intracellular lipids, and high glucose. Additionally, extensive studies have elucidated that diabetes accelerates the odds of atherosclerosis with the explanation that these two chronic disorders share some common mechanisms, such as endothelial dysfunction and inflammation. In this review, we initially summarize the current research and proposed mechanisms and then highlight the role of these three cell types in diabetes-accelerated atherosclerosis and finally establish the mechanism pinpointing the relationship between diabetes and atherosclerosis. Graphical Abstract Initiation and progression of diabetic atherosclerosis. Insulin resistance with hyperinsulinemia, hyperglycemia and lipotoxicity contribute to multiple processes including AGEs production, increased FFA and ox-LDL, which together lead to endothelial dysfunction, macrophages-derived foam cell formation, and VSMCs phenotypic switch. In the early stages of diabetic atherosclerosis, circulating monocytes bind to adhesion factors expressed by activated endothelial cell, while endothelial cells release chemokines that promote migration of the bound monocytes into the arterial wall. After entering the intima, monocytes mature into macrophages, including pro-inflammatory M1 and anti-inflammatory M2 types, macrophages engulf retained ox-LDL and transform into lipidloaded macrophage. At the same time, DCs increased local inflammation of endothelial cells and activated VSMCs. VSMCs in the media proliferate and migrate to the intima, forming a fibrous cap to cover the necrotic core. VSMCs and macrophages can undergo cell death, including apoptosis, pyroptosis, ferroptosis, necroptosis, cell fragments gathered and formed lipid-rich necrotic cores. Fiber caps became thinner, plaque vulnerability increased and rupture, platelet activation led to the formation of thrombosis, and NETosis promoted the formation of thrombosis.
- Open Access
- 19 January 2023
- Published by AccScience Publishing in Global Translational Medicine
- Vol. 2 (1) , 241
Role of stem cells in aortic aneurysm
In recent years, aortic aneurysms (AAs) have attracted increasing attention due to their asymptomatic onset and high mortality. In clinic, surgery and anti-hypertensive or lipid-lowering medicine is usually applied in the treatments of AA. However, AA is prone to relapse and sudden rupture may happen. Therefore, more effective prevention and treatment methods are urgently needed. Stem cells are believed to play a crucial role in vascular formation and regeneration of damaged tissues during vascular disease progression. With the development of single-cell RNA sequencing analysis, many populations of stem cells have been discovered in AA tissues. Recent studies have demonstrated that they may participate in the occurrence or development of AAs. Besides, there is a prospect in clinical treatment for AAs when regenerative medicine with stem cells comes into the picture. This review mainly discusses the latest findings on the crucial roles of stem cells in AAs as well as their potential therapeutic strategies of stem cells, which provides some references for the prevention, diagnosis, and treatment of AAs. Further studies are needed to explore the novel application of stem cell therapies for AAs.
- 19 January 2023
- Published by AccScience Publishing in Global Translational Medicine
- Vol. 2 (1) , 241
Open AccessRole of stem cells in aortic aneurysm
In recent years, aortic aneurysms (AAs) have attracted increasing attention due to their asymptomatic onset and high mortality. In clinic, surgery and anti-hypertensive or lipid-lowering medicine is usually applied in the treatments of AA. However, AA is prone to relapse and sudden rupture may happen. Therefore, more effective prevention and treatment methods are urgently needed. Stem cells are believed to play a crucial role in vascular formation and regeneration of damaged tissues during vascular disease progression. With the development of single-cell RNA sequencing analysis, many populations of stem cells have been discovered in AA tissues. Recent studies have demonstrated that they may participate in the occurrence or development of AAs. Besides, there is a prospect in clinical treatment for AAs when regenerative medicine with stem cells comes into the picture. This review mainly discusses the latest findings on the crucial roles of stem cells in AAs as well as their potential therapeutic strategies of stem cells, which provides some references for the prevention, diagnosis, and treatment of AAs. Further studies are needed to explore the novel application of stem cell therapies for AAs.
- Open Access
- 30 November 2022
- Published by MDPI AG in Antioxidants
- Vol. 11 (12) , 2378
Peroxisome Proliferator-Activated Receptor α Attenuates Hypertensive Vascular Remodeling by Protecting Vascular Smooth Muscle Cells from Angiotensin II-Induced ROS Production
Vascular remodeling is the fundamental basis for hypertensive disease, in which vascular smooth muscle cell (VSMC) dysfunction plays an essential role. Previous studies suggest that the activation of peroxisome proliferator-activated receptor α (PPARα) by fibrate drugs has cardiovascular benefits independent of the lipid-lowering effects. However, the underlying mechanism remains incompletely understood. This study explored the role of PPARα in angiotensin II (Ang II)-induced vascular remodeling and hypertension using VSMC-specific Ppara-deficient mice. The PPARα expression was markedly downregulated in the VSMCs upon Ang II treatment. A PPARα deficiency in the VSMC significantly aggravated the Ang II-induced hypertension and vascular stiffness, with little influence on the cardiac function. The morphological analyses demonstrated that VSMC-specific Ppara-deficient mice exhibited an aggravated vascular remodeling and oxidative stress. In vitro, a PPARα deficiency dramatically increased the production of mitochondrial reactive oxidative species (ROS) in Ang II-treated primary VSMCs. Finally, the PPARα activation by Wy14643 improved the Ang II-induced ROS production and vascular remodeling in a VSMC PPARα-dependent manner. Taken together, these data suggest that PPARα plays a critical protective role in Ang II-induced hypertension via attenuating ROS production in VSMCs, thus providing a potential therapeutic target for hypertensive diseases.
- 30 November 2022
- Published by MDPI AG in Antioxidants
- Vol. 11 (12) , 2378
Open AccessPeroxisome Proliferator-Activated Receptor α Attenuates Hypertensive Vascular Remodeling by Protecting Vascular Smooth Muscle Cells from Angiotensin II-Induced ROS Production
Vascular remodeling is the fundamental basis for hypertensive disease, in which vascular smooth muscle cell (VSMC) dysfunction plays an essential role. Previous studies suggest that the activation of peroxisome proliferator-activated receptor α (PPARα) by fibrate drugs has cardiovascular benefits independent of the lipid-lowering effects. However, the underlying mechanism remains incompletely understood. This study explored the role of PPARα in angiotensin II (Ang II)-induced vascular remodeling and hypertension using VSMC-specific Ppara-deficient mice. The PPARα expression was markedly downregulated in the VSMCs upon Ang II treatment. A PPARα deficiency in the VSMC significantly aggravated the Ang II-induced hypertension and vascular stiffness, with little influence on the cardiac function. The morphological analyses demonstrated that VSMC-specific Ppara-deficient mice exhibited an aggravated vascular remodeling and oxidative stress. In vitro, a PPARα deficiency dramatically increased the production of mitochondrial reactive oxidative species (ROS) in Ang II-treated primary VSMCs. Finally, the PPARα activation by Wy14643 improved the Ang II-induced ROS production and vascular remodeling in a VSMC PPARα-dependent manner. Taken together, these data suggest that PPARα plays a critical protective role in Ang II-induced hypertension via attenuating ROS production in VSMCs, thus providing a potential therapeutic target for hypertensive diseases.
- 17 May 2022
- Published by Springer Nature
- Vol. 1377, 141-151
HDL Mimetic Peptides
Since therapeutic strategies designed to raise HDL failed to exert the expected effective cardiovascular disease (CVD) outcomes in clinical trials, how to improve HDL function rather than its plasma level has become a new focus of scientists’ attention. Numerous HDL mimetic peptides have been designed and investigated in various animal models in recent years. Although the underlying mechanisms are not fully understood, the peptides’ antiatherogenic effects, such as acceleration of RCT and improvement of natural HDL function without necessarily raising its level, showed a promising therapeutic role in the prevention of atherosclerosis and other diseases. This chapter reviews recent studies on the roles and potentials of HDL mimetic peptides in atherosclerosis-related CVD. Keywords Cardiovascular disease HDL Mimetic peptide Reverse cholesterol transport
- 17 May 2022
- Published by Springer Nature
- Vol. 1377, 141-151
HDL Mimetic Peptides
Since therapeutic strategies designed to raise HDL failed to exert the expected effective cardiovascular disease (CVD) outcomes in clinical trials, how to improve HDL function rather than its plasma level has become a new focus of scientists’ attention. Numerous HDL mimetic peptides have been designed and investigated in various animal models in recent years. Although the underlying mechanisms are not fully understood, the peptides’ antiatherogenic effects, such as acceleration of RCT and improvement of natural HDL function without necessarily raising its level, showed a promising therapeutic role in the prevention of atherosclerosis and other diseases. This chapter reviews recent studies on the roles and potentials of HDL mimetic peptides in atherosclerosis-related CVD. Keywords Cardiovascular disease HDL Mimetic peptide Reverse cholesterol transport